Cargando…

Oral health status of patients with multiple myeloma

OBJECTIVE: To describe the oral health status of patients with multiple myeloma and compare to a control group. MATERIALS AND METHODS: The medical history of the studied subjects was obtained from the medical records and through interviews. Trained examiners evaluated the oral mucosa, teeth, periodo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feitosa, Édila Figuerêdo, Magalhães, Roberto José Pessoa, Barbosa, Carlos Augusto de Melo, Guedes, Fabio Ribeiro, Maiolino, Angelo, Torres, Sandra Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248491/ https://www.ncbi.nlm.nih.gov/pubmed/31582338 http://dx.doi.org/10.1016/j.htct.2019.01.012

Ejemplares similares

Can dentists detect multiple myeloma through oral manifestations?
por: Almeida, Thaís Miranda Xavier de, et al.
Publicado: (2018)

CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil
por: Hungria, Vania, et al.
Publicado: (2023)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

Detection of human papillomavirus in dental biofilm and the uterine cervix of a pregnant adolescent: Detecção do papilomavírus humano em biofilme dental e no colo uterino de uma adolescente grávida
por: Cavalcanti, Édila Figuerêdo Feitosa, et al.
Publicado: (2015)

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
por: Hungria, Vania, et al.
Publicado: (2020)

COVID-19 in Multiple Myeloma Patients: Frequencies and Risk Factors for Hospitalization, Ventilatory Support, Intensive Care Admission and Mortality -Cooperative Registry from Grupo Brasileiro De Mieloma Multiplo (GBRAM)
por: Garnica, Marcia, et al.
Publicado: (2021)

Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
por: Maiolino, Angelo, et al.
Publicado: (2023)

Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil
por: Salgado, Anna Beatriz dos Santos, et al.
Publicado: (2023)

B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients
por: Mendonça de Pontes, Robéria, et al.
Publicado: (2021)

The frequency of oral conditions detected in hematology inpatients
por: Gomes, Alessandra Oliveira Ferrari, et al.
Publicado: (2018)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

PB2095: ELOTUZUMAB OR DARATUMUMAB IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE (EPD AND DPD) IN RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM): A NETWORK META-ANALYSIS
por: Decimoni, Tassia Cristina, et al.
Publicado: (2023)

Multiple myeloma with presentation in the oral cavity
por: Kamath, Pooja, et al.
Publicado: (2022)

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis
por: Dimopoulos, Meletios A., et al.
Publicado: (2022)

Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context
por: Segges, P., et al.
Publicado: (2016)

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I
por: Maiolino, Angelo, et al.
Publicado: (2022)

Interaction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT)
por: Trigo, Fernanda M.B., et al.
Publicado: (2014)

Consolidation in multiple myeloma – current status and perspectives
por: Olszewska-Szopa, Magdalena, et al.
Publicado: (2014)

Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2017)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
por: Ria, Roberto, et al.
Publicado: (2020)

Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma()
por: Crusoé, Edvan de Queiroz, et al.
Publicado: (2021)

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma
por: Ria, Roberto, et al.
Publicado: (2020)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

P954: MULTIPLE MYELOMA IN LATIN AMERICA CANCER REGISTRY: THE MYLACRE STUDY
por: Hungria, Vania, et al.
Publicado: (2023)

RENAL STATUS OF MULTIPLE MYELOMA PATIENTS IN IBADAN, NIGERIA
por: Fasola, F.A, et al.
Publicado: (2012)

Minimal residual disease in multiple myeloma: current status
por: Ding, Hong, et al.
Publicado: (2021)

Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
por: Abramson, Hanley N.
Publicado: (2023)

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
por: Giannopoulos, K, et al.
Publicado: (2012)

Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022)

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease
por: Guedes, Alex, et al.
Publicado: (2023)

Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
por: Berardi, Simona, et al.
Publicado: (2013)

MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021)

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012
por: Hungria, Vânia Tietsche de Moraes, et al.
Publicado: (2013)

PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?
por: Crusoe, E., et al.
Publicado: (2022)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

New Insights in Anti-Angiogenesis in Multiple Myeloma
por: Ribatti, Domenico, et al.
Publicado: (2018)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

PB2278: INVESTIGATION ON THE STATUS OF INFECTION IN PATIENTS WITH MULTIPLE MYELOMA
por: Lan, D., et al.
Publicado: (2022)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_deolldp8soodshglq04ecbu6dl